New CRISPR approach shows promise for treating glioblastoma

The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes.

Former MIT biologist, who lost positions after engaging in a prohibited sexual relationship, accepts new science position in Prague

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is

November 13, 2023

FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear

The Food and Drug Administration issued a change to the warning label for Legend Biotech and Janssen’s myeloma CAR-T, Carvykti or cilta-cel, adding that some

December 22, 2023

FTC and DOJ propose changes that could slow dealmaking review process

The Federal Trade Commission and Justice Department have proposed changes to the merger review process that could extend the amount of time and documentation it

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.